| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 2954 | 2011 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1322 | 2013 |
| Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind … G Comi, V Martinelli, M Rodegher, L Moiola, O Bajenaru, A Carra, ... The Lancet 374 (9700), 1503-1511, 2009 | 782 | 2009 |
| Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus W Yang, N Shen, DQ Ye, Q Liu, Y Zhang, XX Qian, N Hirankarn, D Ying, ... PLoS genetics 6 (2), e1000841, 2010 | 458 | 2010 |
| Quality of life in multiple sclerosis: measuring the disease effects more broadly MW Nortvedt, T Riise, KM Myhr, HI Nyland Neurology 53 (5), 1098-1098, 1999 | 448 | 1999 |
| Discriminating variable test and selectivity ratio plot: quantitative tools for interpretation and variable (biomarker) selection in complex spectral or chromatographic profiles T Rajalahti, R Arneberg, AC Kroksveen, M Berle, KM Myhr, OM Kvalheim Analytical chemistry 81 (7), 2581-2590, 2009 | 396 | 2009 |
| Disease‐modifying treatments for multiple sclerosis–a review of approved medications Ø Torkildsen, KM Myhr, L Bø European journal of neurology 23, 18-27, 2016 | 380 | 2016 |
| Depression and anxiety amongst multiple sclerosis patients AG Beiske, E Svensson, I Sandanger, B Czujko, ED Pedersen, ... European journal of neurology 15 (3), 239-245, 2008 | 374 | 2008 |
| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 367 | 2015 |
| The cuprizone model for demyelination Ø Torkildsen, LA Brunborg, KM Myhr, L Bø Acta neurologica scandinavica 117, 72-76, 2008 | 365 | 2008 |
| IL‐6: an early marker for outcome in acute ischemic stroke U Waje‐Andreassen, J Kråkenes, E Ulvestad, L Thomassen, KM Myhr, ... Acta Neurologica Scandinavica 111 (6), 360-365, 2005 | 321 | 2005 |
| Health-related quality of life among young adults with ischemic stroke on long-term follow-up H Naess, U Waje-Andreassen, L Thomassen, H Nyland, KM Myhr Stroke 37 (5), 1232-1236, 2006 | 316 | 2006 |
| Guidelines on use of anti‐IFN‐β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN‐β antibodies in multiple sclerosis PS Sørensen, F Deisenhammer, P Duda, R Hohlfeld, KM Myhr, J Palace, ... European journal of neurology 12 (11), 817-827, 2005 | 311 | 2005 |
| Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis MW Nortvedt, T Riise, J Frugaård, J Mohn, A Bakke, AB Skår, H Nyland, ... Multiple Sclerosis Journal 13 (1), 106-112, 2007 | 300 | 2007 |
| Biomarker discovery in mass spectral profiles by means of selectivity ratio plot T Rajalahti, R Arneberg, FS Berven, KM Myhr, RJ Ulvik, OM Kvalheim Chemometrics and Intelligent Laboratory Systems 95 (1), 35-48, 2009 | 285 | 2009 |
| Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study HMB Lunde, J Assmus, KM Myhr, L Bø, N Grytten Journal of Neurology, Neurosurgery & Psychiatry 88 (8), 621-625, 2017 | 257 | 2017 |
| Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction MW Nortvedt, T Riise, KM Myhr, AM Landtblom, A Bakke, HI Nyland Multiple Sclerosis Journal 7 (4), 231-235, 2001 | 248 | 2001 |
| Effect of dietary advice and n‐3 supplementation in newly diagnosed MS patients I Nordvik, KM Myhr, H Nyland, KS Bjerve Acta Neurologica Scandinavica 102 (3), 143-149, 2000 | 243 | 2000 |
| Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension KM Myhr, T Riise, C Vedeler, MW Nortvedt, M Grønning, R Midgard, ... Multiple Sclerosis Journal 7 (1), 59-65, 2001 | 220 | 2001 |
| A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes NF Magitta, AS Bøe Wolff, S Johansson, B Skinningsrud, BA Lie, KM Myhr, ... Genes & Immunity 10 (2), 120-124, 2009 | 219 | 2009 |
